Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "Addiction Biology"
DOI: 10.1111/adb.13182
Abstract: Ibudilast, a neuroimmune modulator, shows promise as a pharmacotherapy for alcohol use disorder (AUD). In vivo administration of ibudilast reduces the expression of pro‐inflammatory cytokines in animal models, but its effects on markers of inflammation… read more here.
Keywords: use disorder; ibudilast; markers inflammation; alcohol use ... See more keywords